SAM, Linklaters, JSA Act On Biocon’s $460 Million QIP Biopharamaceuticals January 19, 2026 Capital Markets
CAM, SAM, Sidley, S&R Advised On IPAMC’s ₹10,600 Cr IPO Asset Management & Funds December 24, 2025 Capital Markets – Equity
CAM, SAM Advised On Urban Company’s ₹1900 Cr IPO Online Services Marketplace September 22, 2025 Capital Markets – Equity
